Johnson & Johnson Buy📈 NYSE:JNJ Long D1
🛒Buy above = 168.04
🎯Target1 = 173.36
🎯Target2 = 176.65
🎯Target3 = 181.98
⛔️Stop-loss = 159.42
❌Cancel trade = 159.42
Johnson_and_johnson
If chart goes up black line !EVERYTHING IS POSSIBLE! (Big event)If chart goes up black line !EVERYTHING IS POSSIBLE! (Big event)
And to 24 FEB to 8 MARS= 2 choices
1: The bottom after the big bull Event! ( around 5.48$- 5.67$ ) after that another bull because is the max bottom line.
OR
2: The maximun Bull trend ( if the chart doesn't go up the black line ) and after that bear trend. ( the bottom will be 4.50$.. something around that)
I choose option 1 because :
-spyk etf J&J Vaccine efficacity will be on top at this time.
-WEED will be legalize in entire USA in this period too
-is the fucking futur soo bull all in!! imposible human can go futher with out fixed mental issue! mental issue is not imagination for creation! mental issue are BIG WALLS. and everyone know right now we are at the top of thechnologie. SOMETHING BIG WILL CHANGE. LIKE THE INITIATION OF INTERNET.
MAYBE CLOUD INTERNET...LIMITLESS PERFOMANCE.
MAYBE REAL A.I ACESSIBILITY
MAYBE ROBOT WHO TAKE PHYSICALL WORKS
MAYBE EVERYTHING WILL BE AUTOMATIC IN A WAY THAT CHANGE ALL OUR ENTIRE HABITS ( COVID IS A GOOD INICIATION)
Mid Term J&J sketch. Johnson & Johnson. Post close of NYSE -1/26/2021.
My sketch of J&J indicates:
that we have broken above LT trend line and have gained momentum ahead of ST Trend line.
we have a perfect FB setup with a Retrace to? 0.5 is my guess.
interested to see if Momentum indicates a strong trend redirect and the beginning of a fourth EW.
Note: I did not use support / Resistance in this chart but may take a look tomorrow at shorter time frame to see where the daily traders are pressuring.
Cheers !
J&J target price at $180.35 +17%J&J has activated a second impulse structure with target price at $180.35 that is +17% from current price. This value has as well a bigger second impulse structure activated with target price $228.66 +48% from current price.
NYSE:JNJ Johnson stock price forecast, Buy Breakout, Target 226.Johnson & Johnson (NYSE: JNJ)
Trade : Buy Breakout
Entry : 158
Target : 226.31 (68.31, +43.23%)
Stop : 145 (-13, -8.23%)
Posted on Sunday, December 13, 2020
Note : Johnson & Johnson stock price hasn't moved for a long time. Stocks like this, once they begin to move, often show very big moves. Not sure yet, but JNJ stock seems to be preparing for a rise. It would be better to find opportunities to buy when the price break out 158.0. If the prediction is right, resistances could be 158, 182.60 and 226.31. Supports could be 146.71 and 133.28. If they have been preparing something very big, there is a possibility that their stock price could rise over 270 level.
Technical outlook: JNJ bullish scenario:Technical outlook:
JNJ bullish scenario:
We have technical figure Triangle in US company Johnson & Johnson (JNJ) at daily chart. Johnson & Johnson is an American multinational corporation founded in 1886 that develops medical devices, pharmaceutical, and consumer packaged goods. Its common stock is a component of the Dow Jones Industrial Average and the company is ranked No. 37 on the 2018 Fortune 500 list of the largest United States corporations by total revenue. The Triangle has broken through the resistance line at 09/12/2020, if the price holds above this level we can have possible bullish price movement with forecast for the next 13 days towards 158.15 USD. Our stop loss order should be placed at 143.06 USD if we decide to enter this position.
Fundamentals:
- Mexico could order an additional 22 million doses of coronavirus vaccine from Johnson & Johnson’s Janssen unit under a memorandum of understanding signed this week, Deputy Health Minister Hugo Lopez-Gatell said on Tuesday.
JNJ - buy support zone (gray) analysisHello traders,
Description of the analysis:
Johnson & Johnson ( JNJ ) support zones ideal for timing long positions (gray). Trade what you understand, trade carefully and sparingly according to the business plan.
About me:
Hi, my name is Jacob Kovarik and I´m trading on stock exchange since 2008. I started with a capital of 3000 USD. My first strategy was based on OTM options. (American stock index and their ETF ). I´ve learnt on my path that professional trading is based on two main fundaments which have to complement each other, to make a bussiness attitude profitable. I´ve tried a lot of techniques and many manners how to analyze the market. From basic technical analysis to fundamental analysis of single title. My analytics gradually changed into professional attitude. I work with logical advantages of stock exchange (return of value back to average, volume , expected volatility , advantage of high stop-loss, the breakdown of time in options, statistics and cosistent thorough control of risk). At the moment, my main target is ITM on SPM index. Biggest part of my current bussiness activity comes from e mini futures (NQ, ES). I´m trader of positions. I´m from Czech republic and I take care of a private fund (over $4.000.000 USD). During my career I´ve earned a lot of valuable experience, such as functionality of strategies and what is more important, control of emotions. Professional trading is, in my opinion, certain kind of mental training and if we are able to control our emotions, accomplishment will show up. I will share with you my analysis and trades on my profile. I wish to all of you successul trades.
Jacob
Johnson and Johnson - JNJ top-down video AnalysisHello everyone, here is the top-down analysis for JNJ, feel free to request any pair/instrument or ask any questions in the comment section below.
Best of luck!
Looking for a break from bull flag for Johnson & JohnsonIf the Johnson & Johnson COVID-19 vaccine does well in final phase testing, this could cause the share price to break out from the current bull flag formation, if not we will see a break to the downside.
MRNA- Leader in the vaccine race. Ladder buy to avoid the riskModerna is the first company to start the phase 3 trial in July and could have the supply ready earliest by Oct and accelerated approval earliest by December, according to Nami Sumida/BioPharma Dive and morningstar.
Other competitors are scheduled to have accelerated approval the earliest around early 2021.
Johnson & Johnson Earnings Estimates Q2 2020$JNJ reports earnings 07/16/2020
The above chart consists of earnings estimates (source: Yahoo Finance Premium) and a technical analysis.
JNJ descending channelJohnson's and Johnson's is in a descending channel for more than two months . watch the resistance and support once there is a breakout it might lead to a strong trend upward or downward depending which line will break resistance or support !
